Ftse Mib
35.398,82
-0,03%
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
NASDAQ
16.685,97
-0,07%
Bitcoin
66.906,52
-0,26%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Moberg Pharma Ab (publ) (0P48) Moberg Pharma Ab (publ) (0P48) Notizie

0P48

Moberg Pharma Ab (publ) (0P48)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:0P48
DataOraFonteTitoloSimboloCompagnia
07/02/202408:12UK RegulatoryMOB-015 is launched in Sweden under the brand name Terclara- pharmacies report major demand for the new medicationLSE:0P48Moberg Pharma Ab (publ)
28/06/202311:23PR Newswire (US)MOB-015 is recommended for approval in EU: Moberg PharmaLSE:0P48Moberg Pharma Ab (publ)
28/03/202208:10PR Newswire (US)European marketing authorization application for MOB-015 submittedLSE:0P48Moberg Pharma Ab (publ)
23/12/202108:12PR Newswire (US)The Medical Products Agency in Sweden will be reference member state for Moberg Pharma's European registration applicationLSE:0P48Moberg Pharma Ab (publ)
22/09/202108:22PR Newswire (US)Moberg Pharma receives approval from the EMA's Paediatric CommitteeLSE:0P48Moberg Pharma Ab (publ)
09/02/202108:13PR Newswire (US)Moberg Pharmas Year-end report 2020LSE:0P48Moberg Pharma Ab (publ)
29/01/202113:23PR Newswire (US)Moberg Pharma: Announcement of terms for the fully guaranteed rights issue in OncoZenge, timetable for the listing and record...LSE:0P48Moberg Pharma Ab (publ)
29/01/202108:37PR Newswire (US)New number of shares and votes in Moberg Pharma AB (publ)LSE:0P48Moberg Pharma Ab (publ)
07/01/202108:08PR Newswire (US)OncoZenge announces issue of European Patent related to BupiZenge®LSE:0P48Moberg Pharma Ab (publ)
11/12/202008:07PR Newswire (US)OncoZenge raises MSEK 10 ahead of spin-off and separate listingLSE:0P48Moberg Pharma Ab (publ)
30/11/202014:33PR Newswire (US)Moberg Pharma obtains positive decision from the Swedish Tax Agency regarding the Lex Asea distribution of the shares in Onco...LSE:0P48Moberg Pharma Ab (publ)
23/11/202008:41PR Newswire (US)Invitation to market update in Moberg Pharma on November 25thLSE:0P48Moberg Pharma Ab (publ)
16/11/202015:16PR Newswire (US)OncoZenge secures approximately SEK 70 million in financing ahead of spin-off and separate listingLSE:0P48Moberg Pharma Ab (publ)
10/11/202009:02PR Newswire (US)Extended fiscal year July 2019 - December 2020 Interim report July - September 2020LSE:0P48Moberg Pharma Ab (publ)
06/11/202008:26PR Newswire (US)Moberg Pharma decides on fully guaranteed rights issue of approximately SEK 150 millionLSE:0P48Moberg Pharma Ab (publ)
06/11/202008:25PR Newswire (US)Moberg Pharma intends to distribute and separately list BupiZenge® (BUPI)LSE:0P48Moberg Pharma Ab (publ)
14/10/202008:27PR Newswire (US)Moberg Pharma intends to submit a registration application in Europe in 2021LSE:0P48Moberg Pharma Ab (publ)
11/08/202008:16PR Newswire (US)Moberg Pharma: Interim report April - June 2020LSE:0P48Moberg Pharma Ab (publ)
30/07/202008:27PR Newswire (US)Appointment of Chief Medical Officer at Moberg PharmaLSE:0P48Moberg Pharma Ab (publ)
30/06/202008:28PR Newswire (US)New number of Shares and Votes in Moberg Pharma AB (publ)LSE:0P48Moberg Pharma Ab (publ)
25/06/202008:26PR Newswire (US)Moberg Pharma Meets Primary Endpoint in the European Phase 3 StudyLSE:0P48Moberg Pharma Ab (publ)
29/05/202008:13PR Newswire (US)New Number of Shares and Votes in Moberg Pharma AB (publ)LSE:0P48Moberg Pharma Ab (publ)
12/05/202008:24PR Newswire (US)Extended Fiscal Year July 2019 - December 2020 Interim Report January - March 2020LSE:0P48Moberg Pharma Ab (publ)
05/05/202008:14PR Newswire (US)Moberg Pharma's Interim Report for July 2019 - March 2020 to be Published on May 12 - Invitation to TeleconferenceLSE:0P48Moberg Pharma Ab (publ)
27/03/202009:20PR Newswire (US)Notice of Extraordinary General Meeting in Moberg Pharma AB (publ)LSE:0P48Moberg Pharma Ab (publ)
23/03/202021:17PR Newswire (US)Moberg Pharma Enters Financing Agreement of Up To SEK 216 Million for Further Investments in MOB-015LSE:0P48Moberg Pharma Ab (publ)
11/02/202008:18PR Newswire (US)Moberg Pharma AB Interim Report October - December 2019LSE:0P48Moberg Pharma Ab (publ)
04/02/202008:13PR Newswire (US)Moberg Pharma's Interim Report to be Published on February 11 - Invitation to TeleconferenceLSE:0P48Moberg Pharma Ab (publ)
22/01/202008:21PR Newswire (US)Expert Evaluation Clarifies Phase 3 Results and Provides Strong Support for MOB-015LSE:0P48Moberg Pharma Ab (publ)
12/12/201908:10PR Newswire (US)Moberg Pharma Comments on the Results of the North American Phase 3 Study With MOB-015LSE:0P48Moberg Pharma Ab (publ)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:0P48

La tua Cronologia

AMEX
GOP
NASDAQ
FXVOUX
FTP Select DSIP Portfoli...
KOSPI
023450
Dongnam Chemical Co Lte
BIT
P1ELW4
BNP Paribas Issuance
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network